Published online 23 March 2010 Nature 464, 479 (2010) doi:10.1038/464479a
US health bill promises changes for biomedical researchers
Translational work set to receive a boost.
Meredith Wadman
The historic health-care bill that passed the US House of Representatives on 21 March includes several lesser-known provisions that will significantly affect biomedical researchers, teaching hospitals and the biotechnology industry.
The final legislation, which is expected to become law, would establish a new competitive grant programme at the National Institutes of Health (NIH). Called the Cures Acceleration Network (CAN), this provision was written into the law
by Senator Arlen Specter (Democrat, Pennsylvania). It will authorize as much as US$500 million annually for speeding the translation of basic discoveries into treatments, through individual awards of up to $15 million per year. The CAN would be separate from an already existing NIH programme called Clinical and Translational Science Awards, which has a budget of roughly $483 million in 2010.
For complete article....
http://www.nature.com/news/2010/100323/full/464479a.html
No comments:
Post a Comment